Update shared on10 Aug 2025
Fair value Increased 1.33%Despite materially improving revenue growth and net profit margin forecasts, Calumet’s consensus analyst price target remains unchanged at $18.80.
What's in the News
- Calumet, Inc. (NasdaqGS:CLMT) has been added to multiple major Russell indices, including the Russell 2000, 2500, and 3000 indices, as well as their corresponding Growth, Value, and Small Cap versions.
- The company is now a constituent in several Russell Growth and Value benchmarks, signaling broader investor recognition from both growth and value perspectives.
- Inclusion in these indices may increase Calumet's visibility and liquidity as a result of index fund buying and institutional tracking.
- The additions span both the main indices and enhanced versions such as the Russell 3000E and Russell 2000 Dynamic Index.
- This broad-based index inclusion reflects Calumet's qualification across a range of market cap, growth, and value methodologies.
Valuation Changes
Summary of Valuation Changes for Calumet
- The Consensus Analyst Price Target remained effectively unchanged, at $18.80.
- The Consensus Revenue Growth forecasts for Calumet has significantly risen from 1.1% per annum to 3.7% per annum.
- The Net Profit Margin for Calumet has significantly risen from 0.69% to 1.50%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.